Advisors Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Advisors Asset Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,145	Closed	-$1.65K	–	1453
2023 Q3	$1.65K	Sell	1,145 -1,940	-63%	-$4.85K	﹤0.01%	1403
2023 Q2	$8.02K	Sell	3,085 -3,845	-55%	-$11.5K	﹤0.01%	1401
2023 Q1	$25.5K	Sell	6,930 -8,659	-56%	-$36.5K	﹤0.01%	1365
2022 Q4	$27.6K	Sell	15,589 -274	-2%	-$729	﹤0.01%	1410
2022 Q3	$63K	Sell	15,863 -41	-0.3%	-$252	﹤0.01%	1331
2022 Q2	$88K	Buy	15,904 +905	+6%	+$7.41K	﹤0.01%	1298
2022 Q1	$220K	Buy	14,999 +5,357	+56%	+$71.7K	﹤0.01%	1206
2021 Q4	$152K	Buy	+9,642	New	+$232K	﹤0.01%	1299

Other funds holding DMTK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Advisors Asset Management's DMTK Position: Q4 2023 in Review

Advisors Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 1,145 shares — an estimated $1.65K sold.

Advisors Asset Management first reported a position in DMTK in Q4 2021 and held it in 8 quarters. The position peaked at $220K in Q1 2022. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

Advisors Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Advisors Asset Management sold 1,145 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $1.65K.
Advisors Asset Management first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Advisors Asset Management's DermTech, Inc. Common Stock position peaked at $220K in Q1 2022.
77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on Advisors Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.